BRISTOL-MYERS SQUIBB CO (BMY:NYSE)
$57.13 0.23 (0.4042%)
Analysed BRISTOL-MYERS SQUIBB CO (BMY:NYSE) News Sources
Bristol Myers Squibb Links Brazil Lung Cancer Access To Long Term Story
09-06-2026
yahoo.com
Nxera Joins OpenFold AI Research Consortium Alongside Leading Global Pharmaceutical and AI Companies to Accelerate AI-enabled Drug Discovery
10-06-2026
yahoo.com
Cytospire Therapeutics Appoints Samit Hirawat, M.D., as Non-Executive Director
10-06-2026
yahoo.com
Harbour BioMed Appoints Dr. Luisa Salter-Cid as Scientific Advisor
11-06-2026
yahoo.com
Takeda’s $4B TYK2 drug tops Bristol Myers’ Sotyktu in head-to-head test
11-06-2026
biopharmadive.com
Bristol Myers Squibb Dividend Raise Streak is 18 Years. Here's 1 Number That Says the Streak Will Continue.
11-06-2026
fool.com
Takeda Designed A Psoriasis Pill Using AI. It Just Walloped Bristol's Sotyktu In A Head-To-Head Test.
11-06-2026
yahoo.com
Why Bristol Myers Squibb (BMY) Outpaced the Stock Market Today
11-06-2026
yahoo.com
Bristol Myers Squibb’s AI Overhaul And Oncology Trials Shape Value Story
12-06-2026
yahoo.com
Can Bristol Myers' Growth Portfolio Offset Legacy Drug Declines?
12-06-2026
yahoo.com
What is the current price of BRISTOL-MYERS SQUIBB CO (BMY:NYSE)?
The current price of BRISTOL-MYERS SQUIBB CO (BMY:NYSE) is $57.13.
BRISTOL-MYERS SQUIBB CO (BMY:NYSE) absolute price change since previous trading day?
The absolute price change of BRISTOL-MYERS SQUIBB CO (BMY:NYSE) since the previous trading day is $0.23.
BRISTOL-MYERS SQUIBB CO (BMY:NYSE) percentage price change since previous trading day?
The percentage price change of BRISTOL-MYERS SQUIBB CO (BMY:NYSE) since the previous trading day is 0.4042%.
What is the most recent average sentiment score for BRISTOL-MYERS SQUIBB CO (BMY:NYSE)?
The most recent average sentiment score for BRISTOL-MYERS SQUIBB CO (BMY:NYSE) is 72 out of 100.
What is the most recent average sentiment for BRISTOL-MYERS SQUIBB CO (BMY:NYSE)?
The most recent sentiment for BRISTOL-MYERS SQUIBB CO (BMY:NYSE) is .
SEC-8K** Filing Available For BRISTOL-MYERS SQUIBB CO (BMY:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.